General Discussion-LDX, page-2

this is a curious company for me... I first bought at $1.25... expecting the FDA approval

you can imagine then I am scraping up funds to buy in the 8 cent range now, post FDA approval

I was not interested at 1 cent, as it seemed they were on the way out... even though they could have survived supplying to all the non USA countries, but they seemed to have expanded to the point of death

but WITH the FDA approval and the share going from 1 cent to 15 cents in two days, one would expect it is back to a 'normal' company.... that is, a product, and market, sales and profit

so I am a bit confused with the recent weakness... why? is there some other product on the market that differentiates in 10 mins between a bacterial and viral chest infection?; all the ducks are lined up as they seemed to be at the $1.20 IPO and subsequent trading before the FDA 'delay'

I ask again, dear friends, is there a competitor product that makes our expected future sales to become nonexistent?